A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation
暂无分享,去创建一个
C. Schmaljohn | B. Hill | M. Sanchez-Lockhart | K. Paolino | S. Kwilas | J. Hooper | M. Josleyn | D. Hannaman | S. Norris | B. Somerville | K. Mills | M. Wisniewski | M. Cohen